Optimizing Therapy Selection, Sequencing in Schizophrenia

References (14)

1. National Collaborating Centre for Mental Health (UK). Psychosis and Schizophrenia in Adults: Treatment and Management. London: National Institute for Health and Care Excellence (UK); 2014.
2. Maroney M. An update on current treatment strategies and emerging agents for the management of schizophrenia. Am J Manag Care. 2020;26(suppl):S55–S61. PubMed
3. Fitzgerald I, O’Dwyer S, Brooks M, et al. Worth the weight? olanzapine prescribing in schizophrenia: a review of weight gain and other cardiometabolic side effects of olanzapine. Front Psychiatry. 2021;12:730769. PubMed CrossRef
4. Rasmussen H, Ebdrup BH, Oranje B, et al. Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients. Int J Neuropsychopharmacol. 2014;17(11):1729–1736. PubMed CrossRef
5. Correll CU, Newcomer JW, Silverman B, et al. Effects of olanzapine combined with samidorphan on weight gain in schizophrenia: a 24-week phase 3 study. Am J Psychiatry. 2020;177(12):1168–1178. PubMed CrossRef
6. Wang M, Tong JH, Zhu G, et al. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study. Schizophr Res. 2012;138(1):54–57. PubMed CrossRef
7. de Silva VA, Suraweera C, Ratnatunga SS, et al. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry. 2016;16(1):341. PubMed CrossRef
8. Goh KK, Chen C-H, Lu M-L. Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials. Int J Psychiatry Clin Pract. 2019;23(1):14–32. PubMed CrossRef
9. Potkin SG, Kane JM, Correll CU, et al. The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research. NPJ Schizophr. 2020;6(1):1. PubMed CrossRef
10. Wagner E, Siafis S, Fernando P, et al. Efficacy and safety of clozapine in psychotic disorders: a systematic quantitative meta-review. Transl Psychiatry. 2021;11(1):487. PubMed CrossRef
11. Chakrabarti S. Clozapine resistant schizophrenia: newer avenues of management. World J Psychiatry. 2021;11(8):429–448. PubMed CrossRef
12. Petrides G, Malur C, Braga RJ, et al. Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study. Am J Psychiatry. 2015;172(1):52–58. PubMed CrossRef
13. Wang G, Zheng W, Li X-B, et al. ECT augmentation of clozapine for clozapine-resistant schizophrenia: a meta-analysis of randomized controlled trials. J Psychiatr Res. 2018;105:23–32. PubMed CrossRef
14. Treatment plans: lessons learned. Family and Caregiver Schizophrenia Discussion Forum. Schizophrenia.com. Published May 2019. Accessed December 6, 2022. https://family.schizophrenia.com/t/treatment-plans-lessons-learned/7788